Long Focus Capital Management’s Oncolytics Biotech ONCY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-40,000
| Closed | -$34.8K | – | 103 |
|
|
2024
Q3 | $34.8K | Hold |
40,000
| – | – | ﹤0.01% | 88 |
|
|
2024
Q2 | $39.6K | Hold |
40,000
| – | – | ﹤0.01% | 89 |
|
|
2024
Q1 | $42.4K | Hold |
40,000
| – | – | ﹤0.01% | 88 |
|
|
2023
Q4 | $54K | Hold |
40,000
| – | – | ﹤0.01% | 97 |
|
|
2023
Q3 | $87.2K | Hold |
40,000
| – | – | ﹤0.01% | 98 |
|
|
2023
Q2 | $104K | Hold |
40,000
| – | – | ﹤0.01% | 99 |
|
|
2023
Q1 | $48K | Hold |
40,000
| – | – | ﹤0.01% | 103 |
|
|
2022
Q4 | $65.2K | Hold |
40,000
| – | – | ﹤0.01% | 98 |
|
|
2022
Q3 | $49K | Hold |
40,000
| – | – | ﹤0.01% | 93 |
|
|
2022
Q2 | $40K | Hold |
40,000
| – | – | ﹤0.01% | 106 |
|
|
2022
Q1 | $63K | Hold |
40,000
| – | – | 0.01% | 97 |
|
|
2021
Q4 | $56K | Buy |
+40,000
| New | +$56K | 0.01% | 95 |
|